Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Research Report 2022 - Market Size, Current Insights and Development Trends

Publisher Name :
Date: 25-Oct-2022
No. of pages: 128

The report focuses on the Glucagon-like Peptide-1 (GLP-1) Agonists market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.

Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Glucagon-like Peptide-1 (GLP-1) Agonists market.

Major Players in the Glucagon-like Peptide-1 (GLP-1) Agonists market are:

Bristol-Myers Squibb

Eli Lily

AstraZeneca

Amylin

Sanofi

Novo Nordisk

GSK

On the basis of types, the Glucagon-like Peptide-1 (GLP-1) Agonists market is primarily split into:

Lixisenatide

Liraglutide

Exenatied

On the basis of applications, the market covers:

Pharmacy

Hospital

Major Regions or countries covered in this report:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Others

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2029

Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Research Report 2022 - Market Size, Current Insights and Development Trends

Table of Content

1 Glucagon-like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Product Overview and Scope of Glucagon-like Peptide-1 (GLP-1) Agonists Market
1.2 Glucagon-like Peptide-1 (GLP-1) Agonists Market Segment by Type
1.2.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Segment by Application
1.3.1 Glucagon-like Peptide-1 (GLP-1) Agonists Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Glucagon-like Peptide-1 (GLP-1) Agonists (2017-2029)
1.5.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Glucagon-like Peptide-1 (GLP-1) Agonists Industry
1.7 Impact of Carbon Neutrality on the Glucagon-like Peptide-1 (GLP-1) Agonists Industry

2 Glucagon-like Peptide-1 (GLP-1) Agonists Market Upstream and Downstream Analysis
2.1 Glucagon-like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Glucagon-like Peptide-1 (GLP-1) Agonists Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream

3 Players Profiles
3.1 Bristol-Myers Squibb
3.1.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Eli Lily
3.2.1 Eli Lily Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.2.4 Business Overview
3.3 AstraZeneca
3.3.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Amylin
3.4.1 Amylin Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Sanofi
3.5.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Novo Nordisk
3.6.1 Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.6.4 Business Overview
3.7 GSK
3.7.1 GSK Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Performance (2017-2022)
3.7.4 Business Overview

4 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Landscape by Player
4.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Share by Player (2017-2022)
4.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Player (2017-2022)
4.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Average Price by Player (2017-2022)
4.4 Global Glucagon-like Peptide-1 (GLP-1) Agonists Gross Margin by Player (2017-2022)
4.5 Glucagon-like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
4.5.1 Glucagon-like Peptide-1 (GLP-1) Agonists Market Concentration Rate
4.5.2 Glucagon-like Peptide-1 (GLP-1) Agonists Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion

5 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price Trend by Type
5.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Market Share by Type (2017-2022)
5.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Market Share by Type (2017-2022)
5.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Price by Type (2017-2022)
5.4 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate of Lixisenatide (2017-2022)
5.4.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate of Liraglutide (2017-2022)
5.4.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue and Growth Rate of Exenatied (2017-2022)

6 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Analysis by Application
6.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption and Market Share by Application (2017-2022)
6.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate of Pharmacy (2017-2022)
6.3.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption and Growth Rate of Hospital (2017-2022)

7 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Region Wise (2017-2022)
7.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Market Share, Region Wise (2017-2022)
7.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2017-2022)

8 Global Glucagon-like Peptide-1 (GLP-1) Agonists Market Forecast (2022-2029)
8.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue Forecast (2022-2029)
8.1.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Price and Trend Forecast (2022-2029)
8.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.3 China Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.5 India Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Glucagon-like Peptide-1 (GLP-1) Agonists Sales and Revenue Forecast (2022-2029)
8.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate of Lixisenatide (2022-2029)
8.3.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate of Liraglutide (2022-2029)
8.3.3 Global Glucagon-like Peptide-1 (GLP-1) Agonists Revenue and Growth Rate of Exenatied (2022-2029)
8.4 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption Forecast by Application (2022-2029)
8.4.1 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption Value and Growth Rate of Pharmacy (2022-2029)
8.4.2 Global Glucagon-like Peptide-1 (GLP-1) Agonists Consumption Value and Growth Rate of Hospital (2022-2029)
8.5 Glucagon-like Peptide-1 (GLP-1) Agonists Market Forecast Under COVID-19

9 Industry Outlook
9.1 Glucagon-like Peptide-1 (GLP-1) Agonists Market Drivers Analysis
9.2 Glucagon-like Peptide-1 (GLP-1) Agonists Market Restraints and Challenges
9.3 Glucagon-like Peptide-1 (GLP-1) Agonists Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Glucagon-like Peptide-1 (GLP-1) Agonists Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Glucagon-like Peptide-1 (GLP-1) Agonists Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Glucagon-like Peptide-1 (GLP-1) Agonists Industry Development

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source
  • Global Cytokine Inhibitor Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Cytokine Inhibitor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The development prospects of cytokine inhibitors are very broad, and these drugs have many medical applications and researches. Cytokine inhibitors can reduce The activity of cytokines, thereby inhibiting their role in immune responses and reducing The activation of immune cells and The occurrence o......
  • Global Microbial Growth Media Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Microbial Growth Media is a nutrient component required by microorganisms, containing a variety of trace elements and trace elements, such as copper, iron, zinc, cobalt, manganese, etc. The global Microbial Growth Media market was valued at US$ 8007 million in 2023 and is anticipated to reach US$ 11530 million by 2030, witnessing a CAGR of 5.3% during The forecast period 2024-2030. The market for microbial growth media is essential in microbiology and biotechnology rese......
  • Global Protein Biochip Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    Protein Biochip is a small Protein array used to quickly detect a large number of unknown proteins. It works in a similar way to a DNA chip. First, a large number of known proteins (such as monoclonal antibodies) are placed on a small substrate and then exposed to and reacted with The unknown protein sample. Due to The specific binding between The antigen and The antibody, it can finally be detected by means of laser. The global Protein Biochip market was valued at US$ 145 million i......
  • Global Isothermal Nucleic Acid Amplification Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 103
    Isothermal nucleic acid amplification is referred to isothermal nucleic acid amplification technology. And in this report, we get The statistics on reagents used in isothermal nucleic acid amplification technology. Nucleic acid isothermal amplification is a newer technique that amplifies DNA or RNA specific fragment from few copies to billion-fold copies under a one temperature condition, unlike PCR amplification that needs at least 30-35 thermal cycles to accomplish The reaction. T......
  • Global Microfluidics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Microfluidics market size was valued at US$ 3118.7 million in 2023. With growing demand in downstream market, the Microfluidics is forecast to a readjusted size of US$ 7707.1 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Microfluidics market. Microfluidics are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 122
    According to our LPI (LP Information) latest study, the global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at US$ 6141.3 million in 2023. With growing demand in downstream market, the Isothermal Nucleic Acid Amplification Technology (INAAT) is forecast to a readjusted size of US$ 11250 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Isothermal Nucleic Acid Amplification Technol......
  • Global Cytokines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 119
    According to our LPI (LP Information) latest study, the global Cytokines market size was valued at US$ 203730 million in 2023. With growing demand in downstream market, the Cytokines is forecast to a readjusted size of US$ 611910 million by 2030 with a CAGR of 17.0% during review period. The research report highlights the growth potential of the global Cytokines market. Cytokines are expected to show stable growth in the future market. However, product differentiation, reducing costs, an......
  • Global Western Blot Imagers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Western Blot Imagers market size was valued at US$ 406 million in 2023. With growing demand in downstream market, the Western Blot Imagers is forecast to a readjusted size of US$ 578.4 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential of the global Western Blot Imagers market. Western Blot Imagers are expected to show stable growth in the future market. However, prod......
  • Global Procalcitonin Antibody Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125
    According to our LPI (LP Information) latest study, the global Procalcitonin Antibody market size was valued at US$ million in 2023. With growing demand in downstream market, the Procalcitonin Antibody is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Procalcitonin Antibody market. Procalcitonin Antibody are expected to show stable growth in the future market. However, product di......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs